—
C+
C+ The full Closelook — membership. Open the C+ overview

Teva Pharma Industries Ltd ADR (TEVA) — Quality & forensics

As of 2026-09-24 — refreshed nightly. Closelook readings from an investment research diary, not ratings or advice.

The Closelook module scores

44 /100 composite · 7 modules · general weight set

Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.

Financial forensics — the academic screens

0.98 Altman Z-Score

Sits in the distress zone (below 1.81). The Z-Score estimates financial-distress risk from five balance-sheet and earnings ratios.

8/9 Piotroski F-Score

Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.

-2.35 Beneish M-Score

Screens reported earnings for statistical manipulation patterns — below the −1.78 manipulation-risk threshold. A screen, not an accusation.

Continue: the TEVA chart & overview · the earnings record

FAQ · from the current data · as of 2026-09-24

Quick answers

What is Teva Pharma Industries Ltd ADR's Closelook quality reading?

The composite reads 44/100 across 7 modules, as of 2026-09-24: valuation 44, quality 47, growth 49, balance sheet 23, cash quality 39, capital allocation 27, momentum 82. Closelook scores are research diary readings, not ratings or investment advice.

What is Teva Pharma Industries Ltd ADR's Altman Z-Score?

0.98, which sits in the distress zone (below 1.81) as of 2026-09-24. The Altman Z-Score estimates financial distress risk from five balance-sheet and earnings ratios.

What is Teva Pharma Industries Ltd ADR's Piotroski F-Score?

8 of 9, as of 2026-09-24. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.

What does Teva Pharma Industries Ltd ADR's Beneish M-Score indicate?

-2.35 — below the −1.78 manipulation-risk threshold, as of 2026-09-24. The M-Score screens reported earnings for statistical manipulation patterns; it is a screen, not an accusation.

Related in the Closelook universe

then Drug Manufacturers - Specialty & Generic, then Healthcare. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.